Danoff has been on the faculty of Johns Hopkins since 2000 where she is actively involved in patient care, teaching, and research. She is particularly focused on myositis-associated ILD in the context of the multidisciplinary Myositis Center. Her research involves clinical and translational studies of interstitial lung disease and autoimmunity. Danoff is a specialist in interstitial lung disease with a particular focus in autoimmune-associated interstitial lung diseases. She is a graduate of Emory University, received her MPhil in Pharmacology from Cambridge University, and her MD and PhD degrees from Johns Hopkins University School of Medicine.ĭr. Danoff is an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the Johns Hopkins University School of Medicine, Co-Director of the Interstitial Lung Disease Program, as well as Associate Director of the Myositis Center. Bourjeily is currently funded by The National Institutes of Health and has received multiple foundations’ grants, including the CHEST Foundation Women’s Lung Health Grant to examine lung disease and sleep in pregnancy.ĭr. She has had a long standing interest in sex differences in lung disease and women’s health and has been a strong advocate for women’s health at Chest. She is ex-officio of the Women's Health NetWork and a member of the Advisory Committee of Women in Pulmonary at CHEST.
Bourjeily runs the lung disease in pregnancy program and is Director of Research and Training at the Miriam Hospital's Women's Medicine Collaborative. Bourjeily is Associate Professor of Medicine at The Miriam Hospital and Brown University and a member of the divisions of pulmonary, critical care, and sleep medicine and obstetric medicine. Dr. The webinar is Monday, April 23, from 2-3 pm CST.ĭr. This webinar is for all practicing clinicians with male and female patients dealing with these pulmonary diseases as well as researchers interested in better understanding the impact of sex and gender on lung diseases. The effects of gender and sex hormones on asthma severity over a lifetime.
#DAWN DEMEO HOW TO#
Ways to recognize differences between women and men in COPD, asthma, and ILD susceptibility symptom presentation, morbidity and mortality and how to apply this to clinical practice.“Investigating and managing patients without taking sex and gender into account could be as imprecise as the omission of a patient’s age from clinical decision making.” “Given that the focus on precision medicine and the study of sex and gender in many fields is relatively new, gaps in the understanding of sex and gender exist with most lung diseases,” stated Dr. They will discuss essential information on what sex and gender differences clinicians should be taking into consideration when treating their female patients with asthma, COPD, and ILD. Ghada Bourjeily, with a panel including Drs. Hence, the large gap in the understanding of the role of sex in disease presentation, diagnosis, and treatment is surprising.Īn upcoming webinar hosted by CHEST will be moderated by Dr. Nearly every cell in the human body has a sex and the latter can influence cell function. Pharmacodynamics and drug metabolism may also differ by sex, with recommendations for different dosing regimens of certain drugs in females. This role may translate into differences in disease susceptibility, presentation, severity and associated outcomes, as well as response to treatment. It is evident, however, that female sex and gender play a clear role in many aspects of lung physiology, biology, and pathology.
Women in Pulmonary Webinar–Sex and Gender Differences in Diagnosing and Treating Asthma, COPD, and ILDīoth sex and gender differences are poorly portrayed in many aspects of lung development and disease and terminology often misused. CHEST Thought Leader Blog Women in Pulmonary Webinar–Sex and Gender Differences in Diagnosing and Treating Asthma, COPD, and ILD
0 kommentar(er)
